Graham Capital Management, L.P. Iovance Biotherapeutics, Inc. Transaction History

Graham Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $6.8 Million - $9.35 Million	-713,101 Reduced 73.63%	255,405 $2.45 Million
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $5.9 Million - $16.9 Million	924,398 Added 2095.76%	968,506 $10.7 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $546,057 - $842,462	44,108 New	44,108 $734,000

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.